| LD SNP | LD R2 | Risk Allele | Gene | Trait Class | Trait | OR/Beta | P-value | Study | Ancestry |
|---|
| 2-203447953-T-A | AFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs114123510-A | WDR12 | Cardiovascular disease | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | 1.13 | 3E-19 | GCST004787 | European, NR |
| 2-203412714-T-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs114393235-G | | Biological process | Smoking initiation | 0.0143 | 1E-30 | GCST90243985 | European, East Asian, Hispanic or Latin American, African unspecified |
| 2-203292850-C-T | AFR:0.22 AMR:0.96 EAS: EUR:1.00 SAS:0.93 10K:0.60 | rs115400054-C | FAM117B | Lipid or lipoprotein measurement | Cholesterol, total | 0.054 | 5E-9 | GCST002896 | European |
| 2-203738256-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs115600411-? | CYP20A1 | Cardiovascular disease | Non-lobar intracerebral hemorrhage (MTAG) | 1.098901 | 1E-6 | GCST008876 | European |
| 2-203738256-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs115600411-G | NR | Hematological measurement | Hemoglobin concentration | | 5E-10 | GCST90002314 | African American or Afro-Caribbean, African unspecified, European, East Asian, Hispanic or Latin American, South Asian |
| 2-203738256-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs115600411-C | CYP20A1 | Other measurement | Periventricular white matter hyperintensities | 0.048 | 7E-8 | GCST010726 | Hispanic or Latin American, European, African American or Afro-Caribbean |
| 2-203738256-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs115600411-C | | Neurological disorder | Insomnia | 0.011 | 2E-10 | GCST90131903 | European |
| 2-203738256-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs115600411-C | | Other measurement | Renin levels | 0.136 | 2E-12 | GCST90249281 | European |
| 2-203738256-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs115600411-? | | Other measurement | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | | 5E-12 | GCST90320825 | European |
| 2-203510795-C-A | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs115654617-A | NBEAL1 | Cardiovascular disease | Coronary artery disease | 0.1179 | 2E-32 | GCST005196 | NR |
| 2-203698452-C-T | AFR:0.93 AMR:0.92 EAS:1.00 EUR:0.97 SAS:1.00 10K:0.95 | rs116219813-T | NR | Hematological measurement | Hemoglobin concentration | 0.018803 | 1E-11 | GCST90002310 | European |
| 2-203514744-A-G | AFR:1.00 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.98 | rs140168762-? | | Cardiovascular disease | Myocardial infarction | 0.9002 | 1E-19 | GCST90432175 | Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR |
| 2-203412489-G-A | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs142250318-? | | Cardiovascular disease | Coronary artery disease or fibrinogen levels (pleiotropy) | | 5E-29 | GCST90129546 | European, South Asian, East Asian, European |
| 2-203310657-A-C | AFR: AMR:0.94 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.86 | rs143805266-? | | Cardiovascular disease | Myocardial infarction | 0.9009 | 2E-19 | GCST90432175 | Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR |
| 2-203267724-G-A | AFR: AMR:0.88 EAS:1.00 EUR:0.98 SAS:0.93 10K:0.84 | rs143911965-A | | Biological process | Smoking initiation | 0.0148 | 1E-32 | GCST90243985 | European, East Asian, Hispanic or Latin American, African unspecified |
| 2-203509563-T-C | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs145538381-? | NBEAL1 | Cardiovascular disease | Non-lobar intracerebral hemorrhage (MTAG) | 1.1111112 | 2E-7 | GCST008876 | European |
| 2-203343235-G-A | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs145664840-A | | Neurological disorder | Insomnia | 0.009 | 3E-11 | GCST90131901 | European |
| 2-203568623-T-C | AFR:0.91 AMR:0.90 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs147932234-? | | Cardiovascular disease | Coronary heart disease | | 1E-10 | GCST90446534 | European |
| 2-203494025-C-T | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs148812085-T | | Cardiovascular disease | Coronary artery disease | 1.121 | 5E-50 | GCST90132314 | European, NR |
| 2-203393957-C-T | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs149163995-? | ALS2CR8 | Cardiovascular disease | Migraine | 1.0822511 | 4E-10 | GCST003986 | European |
| 2-203449759-G-A | AFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs149268645-G | NR | Biological process | Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia | 1.1764705 | 4E-7 | GCST008123 | European |
| 2-203449759-G-A | AFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs149268645-G | NR | Biological process | Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia | 1.1764705 | 4E-7 | GCST008123 | European |
| 2-203333540-G-C | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs150622102-C | | Neurological disorder | Alzheimer's disease | | 3E-8 | GCST90301303 | European, African American or Afro-Caribbean, African unspecified, East Asian, Hispanic or Latin American |
| 2-203521093-T-C | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs181256816-C | | Other measurement | Vertex-wise cortical thickness | 8.87 | 7E-19 | GCST90095131 | European |
| 2-203521093-T-C | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs181256816-C | NR | Other measurement | Cortical surface area | | 8E-15 | GCST90091060 | European |
| 2-203521093-T-C | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs181256816-? | | Other measurement | Personality traits or cognitive traits (multivariate analysis) | | 4E-9 | GCST90270074 | European |
| 2-203521094-G-A | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs185726277-A | NR | Other measurement | Cortical thickness | | 1E-17 | GCST90091061 | European |
| 2-203345718-C-T | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs186399184-? | NR | Other measurement | White matter microstructure (radial diusivities) | | 8E-9 | GCST009540 | European |
| 2-203345718-C-T | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs186399184-? | NR | Other measurement | White matter microstructure (radial diusivities) | | 2E-12 | GCST009540 | European |
| 2-203345718-C-T | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs186399184-? | NR | Other measurement | White matter microstructure (radial diusivities) | | 1E-8 | GCST009540 | European |
| 2-203345718-C-T | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs186399184-? | NR | Other measurement | White matter microstructure (radial diusivities) | | 1E-8 | GCST009540 | European |
| 2-203345718-C-T | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs186399184-? | NR | Other measurement | White matter microstructure (fractional anisotropy) | | 7E-10 | GCST009539 | European |
| 2-203345718-C-T | AFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs186399184-? | NR | Other measurement | White matter microstructure (fractional anisotropy) | | 4E-8 | GCST009539 | European |
| 2-203679497-A-T | AFR:0.93 AMR:0.90 EAS:1.00 EUR:0.91 SAS:0.63 10K:0.91 | rs188186531-A | | Cardiovascular disease | Ischemic stroke (small-vessel) | 1.21 | 4E-7 | GCST005841 | East Asian, European, African American or Afro-Caribbean, South Asian, Asian unspecified, Hispanic or Latin American |
| 2-203473762-T-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs188517380-T | | Cardiovascular measurement | Pulse pressure | 0.02 | 7E-11 | GCST90301701 | European |
| 2-203412444-A-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs191602009-? | | Cardiovascular disease | Migraine (MTAG) | 0.022 | 7E-9 | GCST90269766 | European |
| 2-203412444-A-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs191602009-? | | Cardiovascular disease | Migraine (MTAG) | 0.022 | 7E-9 | GCST90269766 | European |
| 2-203412444-A-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs191602009-? | | Cardiovascular disease | Small vessel stroke (MTAG) | 0.025 | 8E-9 | GCST90103795 | European |
| 2-203412444-A-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs191602009-? | | Cardiovascular disease | Small vessel stroke (MTAG) | 0.025 | 8E-9 | GCST90103795 | European |
| 2-203497785-C-T | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs2351524-? | | Cardiovascular disease | Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | | 2E-24 | GCST90129548 | European, South Asian, East Asian, European |
| 2-203497785-C-T | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs2351524-? | | Cardiovascular disease | Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | | 2E-24 | GCST90129547 | European, South Asian, East Asian, European |
| 2-203497785-C-T | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs2351524-T | NBEAL1 | Other measurement | White matter hyperintensities | | 6E-9 | GCST012580 | European, African American or Afro-Caribbean |
| 2-203382498-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs35212307-? | | Cardiovascular disease | Coronary artery disease | | 5E-49 | GCST90132314 | European, NR |
| 2-203382498-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs35212307-C | WDR12 | Other measurement | White matter hyperintensities | | 4E-8 | GCST012580 | European, African American or Afro-Caribbean |
| 2-203515877-A-G | AFR:0.97 AMR:0.90 EAS:1.00 EUR:0.95 SAS:1.00 10K:0.95 | rs375380888-G | | Other trait | Headache or HbA1c levels | 0.97 | 6E-10 | GCST90281122 | European |
| 2-203497627-A-G | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs4675310-A | | Other trait | Angina pectoris | 0.085 | 4E-9 | GCST90018793 | European, East Asian |
| 2-203497627-A-G | AFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96 | rs4675310-A | | Other measurement | Extensive basal ganglia perivascular space burden | | 3E-9 | GCST90244153 | European |
| 2-203369754-G-A | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs6435169-? | | Cardiovascular disease | Body fat percentage or coronary artery disease (MTAG) | 0.1334 | 7E-10 | GCST90085924 | European, East Asian, South Asian, African American or Afro-Caribbean, European, East Asian, South Asian, African American or Afro-Caribbean, Hispanic or Latin American |
| 2-203369754-G-A | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs6435169-? | | Cardiovascular disease | Body fat percentage or coronary artery disease (MTAG) | 0.1334 | 7E-10 | GCST90085924 | European, East Asian, South Asian, African American or Afro-Caribbean, European, East Asian, South Asian, African American or Afro-Caribbean, Hispanic or Latin American |
| 2-203278940-A-G | AFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85 | rs6705330-G | | Biological process | Smoking initiation | 0.0145 | 1E-31 | GCST90243985 | European, East Asian, Hispanic or Latin American, African unspecified |
| 2-203362617-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs6725887-C | WDR12 | Cardiovascular disease | Myocardial infarction (early onset) | 1.17 | 1E-8 | GCST000340 | European |
| 2-203362617-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs6725887-C | WDR12 | Cardiovascular disease | Coronary heart disease | 1.14 | 1E-9 | GCST000998 | European |
| 2-203362617-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs6725887-C | WDR12 | Cardiovascular disease | Coronary artery disease | 1.14 | 2E-8 | GCST002289 | NR |
| 2-203362617-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs6725887-C | NR | Cardiovascular disease | Coronary artery disease | 1.15 | 6E-8 | GCST011488 | South Asian, European |
| 2-203490535-G-A | AFR:0.28 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.89 | rs6728861-A | NBEAL1 | Cardiovascular disease | Coronary artery disease | 0.1054 | 1E-32 | GCST005195 | NR |
| 2-203413541-C-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs72926767-G | CARF | Cardiovascular disease | Myocardial infarction | 1.12 | 1E-21 | GCST011365 | European, NR, European, NR |
| 2-203413541-C-G | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs72926767-? | | Cardiovascular disease | Myocardial infarction | 0.8998 | 7E-20 | GCST90432175 | Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR |
| 2-203421000-C-T | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs72926772-T | CARF | Cardiovascular disease | Coronary artery disease | 1.13 | 5E-18 | GCST010479 | East Asian, European, East Asian |
| 2-203448861-A-G | AFR: AMR:0.94 EAS: EUR:0.92 SAS:1.00 10K:0.56 | rs72928605-? | FAM117B, ICA1L, WDR12, CARF, NBEAL1, CYP20A1, ABI2 | Other measurement | Brain morphology (MOSTest) | | 1E-8 | GCST010703 | European |
| 2-203456367-T-A | AFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs72928613-? | | Cardiovascular disease | Headache or migraine | | 5E-9 | GCST90267554 | European |
| 2-203463563-A-T | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs72932557-T | CARF | Other measurement | White matter hyperintensities | | 4E-8 | GCST012580 | European, African American or Afro-Caribbean |
| 2-203266227-G-C | AFR: AMR:0.88 EAS:0.94 EUR:0.98 SAS:0.93 10K:0.85 | rs72932727-G | ICA1L | Cardiovascular disease | Non-lobar intracerebral hemorrhage (MTAG) | 1.1111112 | 2E-8 | GCST008876 | European |
| 2-203266227-G-C | AFR: AMR:0.88 EAS:0.94 EUR:0.98 SAS:0.93 10K:0.85 | rs72932727-? | | Neurological disorder | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | | 7E-15 | GCST90132260 | European |
| 2-203277777-A-T | AFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85 | rs72932741-T | | Biological process | Smoking initiation | 0.0145 | 1E-31 | GCST90243985 | European, East Asian, Hispanic or Latin American, African unspecified |
| 2-203533274-T-G | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs72934505-T | NBEAL1 | Other measurement | White matter hyperintensity burden | | 6E-8 | GCST003013 | European, African American or Afro-Caribbean, South East Asian, Hispanic or Latin American, East Asian |
| 2-203533274-T-G | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs72934505-T | NBEAL1 | Other measurement | White matter hyperintensity burden | | 5E-8 | GCST003013 | European, African American or Afro-Caribbean, South East Asian, Hispanic or Latin American, East Asian |
| 2-203533274-T-G | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs72934505-T | ICA1L, WDR12, CARF, NBEAL1, CYP20A1 | Other measurement | White matter hyperintensities | 6.793 | 4E-13 | GCST010101 | European, African unspecified, Hispanic or Latin American, Asian unspecified |
| 2-203533274-T-G | AFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97 | rs72934505-? | ICA1L, WDR12, CARF, NBEAL1, CYP20A1 | Other measurement | White matter integrity (fractional anisotropy) | | 7E-8 | GCST010102 | European |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-T | NBEAL1 | Cardiovascular disease | Coronary artery disease | 0.128 | 2E-32 | GCST005194 | NR |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-T | ICA1L, WDR12, CARF, NBEAL1 | Cardiovascular disease | Lacunar stroke | 1.25 | 4E-9 | GCST90014122 | European |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-T | WDR12, ICA1L, CARF, NBEAL1 | Cardiovascular disease | Lacunar stroke | 1.22 | 5E-8 | GCST90014123 | African American or Afro-Caribbean, European, Hispanic or Latin American |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-? | | Cardiovascular disease | Coronary artery disease or von Willebrand factor levels (pleiotropy) | | 4E-26 | GCST90129544 | European, South Asian, East Asian, European, African American or Afro-Caribbean, Hispanic or Latin American |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-? | | Cardiovascular disease | Coronary artery disease or factor VII levels (pleiotropy) | | 5E-26 | GCST90129542 | European, South Asian, East Asian, European, African American or Afro-Caribbean |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-? | | Cardiovascular disease | Coronary artery disease or factor VIII levels (pleiotropy) | | 4E-26 | GCST90129543 | European, South Asian, East Asian, European, African American or Afro-Caribbean, East Asian, South Asian, Hispanic or Latin American |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-? | | Cardiovascular disease | Coronary artery disease or factor XI levels (pleiotropy) | | 5E-26 | GCST90129545 | European, South Asian, East Asian, European |
| 2-203585748-T-C | AFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49 | rs72934535-C | | Cardiovascular disease | Ischemic heart disease (PheCode 411) | | 7E-9 | GCST008370 | European |
| 2-203607571-T-G | AFR: AMR:0.86 EAS: EUR:0.93 SAS:1.00 10K:0.54 | rs72934556-G | | Other measurement | IDP dMRI TBSS L2 Anterior limb of internal capsule R | 0.11 | 1E-13 | GCST90004139 | European |
| 2-203621853-A-G | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934573-G | | Cardiovascular disease | Myocardial infarction | 0.1351 | 7E-15 | GCST90018877 | European, East Asian |
| 2-203625846-T-G | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934583-T | NBEAL1 | Other measurement | Periventricular white matter hyperintensities | 0.0529 | 1E-9 | GCST010726 | Hispanic or Latin American, European, African American or Afro-Caribbean |
| 2-203625846-T-G | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934583-T | NBEAL1 | Other measurement | White matter hyperintensity volume (adjusted for hypertension) | 0.0627 | 1E-12 | GCST011949 | African American or Afro-Caribbean, African American or Afro-Caribbean, European |
| 2-203625846-T-G | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934583-T | NBEAL1 | Cardiovascular disease | White matter hyperintensity volume x hypertension interaction (2df) | | 5E-12 | GCST011952 | European, African American or Afro-Caribbean |
| 2-203625846-T-G | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934583-T | NBEAL1 | Other measurement | White matter hyperintensity volume | 0.0627 | 7E-13 | GCST011946 | African American or Afro-Caribbean, European |
| 2-203634725-C-T | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934589-? | NBEAL1 | Cardiovascular disease | Non-lobar intracerebral hemorrhage (MTAG) | 1.1111112 | 2E-7 | GCST008876 | European |
| 2-203634725-C-T | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934589-C | | Cardiovascular disease | Small vessel stroke | 1.16 | 7E-7 | GCST90104543 | European |
| 2-203634725-C-T | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934589-C | | Cardiovascular disease | Small vessel stroke (MTAG) | 1.19 | 2E-14 | GCST90162546 | European |
| 2-203636552-G-A | AFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97 | rs72934591-? | | Cardiovascular disease | Myocardial infarction | 0.9014 | 3E-19 | GCST90432175 | Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR |
| 2-203647911-G-A | AFR:0.97 AMR:0.92 EAS:1.00 EUR:0.97 SAS:1.00 10K:0.96 | rs72934601-? | | Other measurement | Brain morphology (MOSTest) | | 1E-14 | GCST90239729 | European |
| 2-203372482-G-A | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs72934760-A | intergenic | Other measurement | Periventricular white matter hyperintensities | 0.054 | 2E-9 | GCST010726 | Hispanic or Latin American, European, African American or Afro-Caribbean |
| 2-203653132-T-G | AFR:0.97 AMR:0.92 EAS:1.00 EUR:0.97 SAS:1.00 10K:0.96 | rs72936304-T | | Other measurement | Renin levels | 0.0821 | 3E-10 | GCST90012038 | European |
| 2-203405678-T-C | AFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs72936869-? | ALS2CR8 | Cardiovascular disease | Non-lobar intracerebral hemorrhage (MTAG) | 1.1111112 | 1E-7 | GCST008876 | European |
| 2-203738174-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs72938315-? | | Other disease | Respiratory diseases | | 2E-8 | GCST007076 | European |
| 2-203738174-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs72938315-C | CYP20A1 | Other measurement | Appendicular lean mass | 0.0207 | 7E-15 | GCST90000025 | European |
| 2-203738174-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs72938315-G | NR | Lipid or lipoprotein measurement | Apolipoprotein B levels | 0.0263 | 2E-14 | GCST90019496 | European, African unspecified, South Asian |
| 2-203738174-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs72938315-G | NR | Lipid or lipoprotein measurement | Total cholesterol levels | 0.027 | 2E-15 | GCST90019501 | European, African unspecified, South Asian |
| 2-203738174-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs72938315-G | NR | Liver enzyme measurement | Serum alkaline phosphatase levels | 0.0305 | 4E-19 | GCST90019494 | European, African unspecified, South Asian |
| 2-203738174-C-G | AFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91 | rs72938315-G | NR | Lipid or lipoprotein measurement | Low density lipoprotein cholesterol levels | 0.0254 | 1E-13 | GCST90019512 | European, African unspecified, South Asian |
| 2-203289818-G-A | AFR: AMR:0.94 EAS:1.00 EUR:1.00 SAS:0.93 10K:0.86 | rs74675536-? | NR | Other measurement | White matter microstructure (mean diusivities) | | 2E-11 | GCST009538 | European |
| 2-203289818-G-A | AFR: AMR:0.94 EAS:1.00 EUR:1.00 SAS:0.93 10K:0.86 | rs74675536-? | NR | Other measurement | White matter microstructure (mean diusivities) | | 5E-8 | GCST009538 | European |
| 2-203369810-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs7582720-? | WDR12 | Cardiovascular disease | Coronary artery disease or ischemic stroke | | 4E-9 | GCST002287 | NR |
| 2-203369810-T-C | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs7582720-? | WDR12 | Cardiovascular disease | Coronary artery disease or large artery stroke | | 3E-8 | GCST002290 | NR |
| 2-203397246-A-G | AFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90 | rs7603972-A | CARF1 | Other measurement | White matter hyperintensity volume | 0.07 | 2E-13 | GCST011947 | European |
| 2-203281673-C-G | AFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85 | rs76122535-G | ICA1L, WDR12, CARF, NBEAL1 | Other measurement | White matter integrity (fractional anisotropy) | 0.360912 | 6E-9 | GCST010102 | European |
| 2-203281673-C-G | AFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85 | rs76122535-G | | Other measurement | White matter fractional anisotropy x age interaction (2df) | | 4E-12 | GCST90100584 | European |
| 2-203280719-C-T | AFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85 | rs78128841-T | | Biological process | Smoking initiation | 0.0145 | 1E-31 | GCST90243985 | European, East Asian, Hispanic or Latin American, African unspecified |